GlassScriptPhysician profile
Maria Diaz
NPI 1841550241
$3,531.16
in general payments reported to CMS, 2019-2025
21 companies · $76.26 in 2025
The $76.26 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $106 · 2021: $2,338 · 2022: $347 · 2023: $379 · 2024: $88.68 · 2025: $76.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $2,061.53 | 2021 | |
| Abbvie INC. | $340.15 | 2019-2023 | Liletta, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $240.57 | 2021-2023 | |
| Gynesonics, INC. | $191.94 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $91.52 | 2019-2021 | |
| Hologic Sales and Service, LLC | $90.36 | 2021-2025 | Acessa Provu System |
| Myriad Women'S Health, INC. | $74.93 | 2023 | Myrisk |
| Organon LLC | $74.92 | 2021-2024 | |
| Coopersurgical, INC. | $62.41 | 2019-2022 | |
| Astellas Pharma US INC | $53.59 | 2023 | Veozah |
| Exeltis, USA INC. | $44.69 | 2021-2025 | Slynd |
| Mylan Pharmaceuticals INC. | $40.17 | 2022 | |
| Allergan, INC. | $31.81 | 2019-2020 | |
| Shield Therapeutics INC | $22.81 | 2025 | |
| Meditrina | $20.99 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $20.13 | 2023 | |
| Merck Sharp & Dohme LLC | $15.93 | 2023 | Gardasil 9 |
| Lupin INC. | $15.08 | 2019 | |
| Amgen INC. | $14.81 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.57 | 2019 | |
| Daiichi Sankyo INC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.